ApoE, irrespective of variant, is believed to play a role in microglial ‘priming’ in early-stage AD by directing their activation towards a DAM phenotype that phagocytose tau-expressing neurons, which, in turn, induces senescence and type I IFN production that is toxic to synapses (Lau et al., 2023). Here, MAPT is linked to Alzheimer disease.